Visual Field Progression is Associated with Systemic Concentration of Macrophage Chemoattractant Protein-1 in Normal-Tension Glaucoma

References

• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–267.
   PubMed Web of Science ®Google Scholar
• Collaborative NTG Study Group. Comparison of glaucomatous progression between untreated patients with NTG and patients with therapeutically reduced IOP. Am J Ophthalmol 1998;126:487–497.
   Google Scholar
• Collaborative NTG Study Group. The effectiveness of IOP reduction in the treatment of NTG. Am J Ophthalmol 1998;126:498–505.
   Google Scholar
• Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001;131:699–708.
   PubMed Web of Science ®Google Scholar
• Lee NY, Park HY, Park CK, Ahn MD. Analysis of systemic endothelin-1, matrix metallorproteinase-9, macrophage chemoattractant protein-1 and high-sensitivity C-reactive protein in normal-tension glaucoma. Curr Eye Res 2013;38:516–519.
   PubMed Web of Science ®Google Scholar
• Schmetterer L, Findl O, Strenn K et al. Effects of endothelin-1 on ocular hemodynamics. Curr Eye Res 1997;16:687–692.
   PubMed Web of Science ®Google Scholar
• Dallinger S, Dorner GT, Wenzel R et al. Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina. Invest Ophthalmol Vis Sci 2000;41:864–869.
   PubMed Web of Science ®Google Scholar
• Lee AJ, Wang JJ, Kifley A, Mitchell P. Open-angle glaucoma and cardiovascular mortality: The Blue Mountains Eye Study. Ophthalmology 2006;113:1069–1076.
   PubMed Web of Science ®Google Scholar
• Iester M, Swindale NV, Mikelberg FS. Sector-based analysis of optic nerve head shape parameters and visual field indices in healthy and glaucomatous eyes. J Glaucoma 1997;6:370–376.
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hyman L, Bengtsson B, Early Manifest Glaucoma Trial group. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999;106:2144–2153.
   Google Scholar
• Allingham RR, Damji KF, Freedman S, Moroi SE, Rhee DJ. Shields textbook of glaucoma, 6th ed. Philadelphia: LWW; 2011: xiii.
   Google Scholar
• Shin WS, Szuba A, Rockson SG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002;160:91–102.
   PubMed Web of Science ®Google Scholar
• Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, Feldmann M, Maini RN. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:38–47.
   PubMed Web of Science ®Google Scholar
• O’Hayre M, Salanga CL, Handel TM, Allen SJ. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J. 2008;409:635–649.
   PubMed Web of Science ®Google Scholar
• Koyama Y, Baba A, Matsuda T. Production of monocyte chemoattractant protein-1 and cytokine-induced neutrophil chemoattractant-1 in rat brain is stimulated by intracerebroventricular administration of an endothelin ETB receptor agonist. Neuroreport 2007;18:1275–1279.
   PubMed Web of Science ®Google Scholar
• Gourmala NG, Buttini M, Limonta S, Sauter A, Boddeke HW. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol 1997;74:35–44.
   PubMed Web of Science ®Google Scholar
• Bethel-Brown C, Yao H, Hu G, Buch S. Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation. J Neuroinflammation 2012;9:262.
   PubMed Web of Science ®Google Scholar
• Curnow SJ, Falciani F, Durrani OM, et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 2005; 46:4251–4259.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009;4:e8158.
   PubMed Web of Science ®Google Scholar
• Mitamura Y, Takeuchi S, Yamamoto S, et al. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy. Jpn J Ophthalmol 2002;46:218–221.
   PubMed Web of Science ®Google Scholar
• Hu DN, Bi M, Zhang DY, Ye F, McCormick SA, Chan CC. Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways. Invest Ophthalmol Vis Sci 2014;55:5760–5769.
   PubMed Web of Science ®Google Scholar
• Chen P, Shibata M, Zidovetzki R, Fisher M, Zlokovic BV, Hofman FM. Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol 2001;116:62–73.
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989;20:1037–1043.
   PubMed Web of Science ®Google Scholar
• Kochanek PM, Hallenbeck JM, Polymorphonuclear leukocytes and monocytermacrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992;23:1367–1379.
   PubMed Web of Science ®Google Scholar
• Drance SM, Fairclough M, Butler DM, Kottler MS.The importance of disc hemorrhage in the prognosis of chronic open angle glaucoma. Arch Ophthalmol 1977;95:226–228.
   PubMedGoogle Scholar
• Kim SH, Park KH. The relationship between recurrent optic disc hemorrhage and glaucoma progression. Ophthalmology 2006;113:598–602.
   PubMed Web of Science ®Google Scholar
• Drance SM, Douglas GR, Wijsman K, Schulzer M, Britton RJ. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol 1988;105:35–39.
   PubMed Web of Science ®Google Scholar
• Buckley C, Hadoke PW, Henry E, O’Brien C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br J Ophthalmol 2002;86:227–232.
   PubMed Web of Science ®Google Scholar
• Gasser P, Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma. Am J Ophthalmol 1991;111:585–588.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Meuer SM, Goetz LA. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1993;34:3024–3027.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Mitchell P, Smith W. Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountains Eye Study. Ophthalmology 1997;104:1714–1719.
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965–1972.
   PubMed Web of Science ®Google Scholar
• Križaj D, Ryskamp DA, Tian N, Tezel G, Mitchell CH, Slepak VZ, Shestopalov VI. From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma. Curr Eye Res 2014;39:105–119.
   PubMed Web of Science ®Google Scholar